Item 5.07 Submission of Matters to a Vote of Security Holders.

The 2022 Annual Meeting of Shareholders of Second Sight Medical Products Inc. ("Second Sight" or "Company") was held on July 27, 2022 (the "Annual Meeting"). Holders of 27,621,649 shares of Second Sight's common stock were represented at the meeting in person or by proxy, constituting a quorum. The following are the voting results on each matter submitted to the shareholders of Second Sight at the annual meeting.

Proposal 1: A proposal to approve the transactions contemplated by the Agreement and Plan of Merger, dated February 4, 2022, by and between the Company and Nano Precision Medical, Inc., a California corporation ("NPM"), pursuant to which NPM will merge with and into NPM Acquisition Corp., a California corporation and a wholly-owned subsidiary of the Company, with NPM surviving as a wholly-owned subsidiary of the Company was approved as set forth below:

Votes For Votes Against Votes Abstained Broker Non-Votes 20,025,356 420,406 157,720 7,018,166

Proposal 2: A proposal to amend the Company's Restated Articles of Incorporation, as amended, to effect a reverse stock split of the Company's common stock, within a range, as determined by the Company's board of directors, of one (1) new share for every two (2) to ten (10) (or any number in between) shares outstanding was approved as set forth below:

Votes For Votes Against Votes Abstained Broker Non-Votes 25,461,881 1,946,693 213,074

           N/A

Proposal 3: A proposal to amend the Company's Restated Articles of Incorporation, as amended, to effect the change of name of the Company to "Vivani Medical, Inc." was approved as set forth below:

Votes For Votes Against Votes Abstained Broker Non-Votes 26,729,124 589,489 303,035

           N/A

Proposal 4: The shareholders elected each of the six director nominees to the Board of Directors of the Company to serve until the 2023 Annual Meeting of Shareholders or until their successors have been duly elected and qualified, as follows:

Name Votes For Votes Withheld Broker Non-Votes Gregg Williams 18,908,597 1,694,885 7,018,166 Aaron Mendelsohn 19,915,717 687,765 7,018,166 Jonathan Will McGuire 19,916,497 686,985 7,018,166 Matthew Pfeffer 19,937,903 665,579 7,018,166 Dean Baker

            18,832,943   1,770,539       7,018,166
Alexandra Larson      19,002,513   1,600,969       7,018,166

Proposal 5: The shareholders approved the Second Sight 2022 Omnibus Plan (the "Second Sight 2022 Plan"), as follows:

Votes For Votes Against Votes Abstained Broker Non-Votes 18,899,357 1,131,344 572,780 7,018,166

Proposal 6: The shareholders, on an advisory basis, ratified the appointment of BPM, LLP. as Second Sight's independent registered public accounting firm for the fiscal year ending December 31, 2022, as follows:

Votes For Votes Against Votes Abstained Broker Non-Votes 27,173,462 293,238 154,948

           N/A

Proposal 7: A proposal to consider and vote upon an adjournment of the Annual Meeting to solicit additional proxies if there were not sufficient votes in favor of the foregoing proposals was not called to a vote because there were sufficient votes in favor of the foregoing proposals.




Item 8.01  Other Events

On July 29, 2022, the Company issued a press release entitled "Second Sight Medical Products Announces Shareholder Approval for its Merger with Nano Precision Medical and other Results of its 2022 Annual Meeting". The press release is attached to this report on Form 8-K as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.






(d)      Exhibits.



  99.1     Press Release "Second Sight Medical Products Announces Shareholder
         Approval for its Merger with Nano Precision Medical and other Results of its
         2022 Annual Meeting" dated July 28, 2022.

104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.

© Edgar Online, source Glimpses